StocksMedium•3 November 2026•
1 min read
Bioventus Forecasts 2026 Revenue Up to $595 Million
Key Facts
1Bioventus expects its 2026 revenue to be in the range of $590 million to $595 million.
2The company reaffirmed its adjusted earnings per share guidance of $0.75 to $0.79.
Bioventus expects its 2026 revenue to be in the range of $590 million to $595 million. Seeking Alpha reported that the company also reaffirmed its adjusted earnings per share guidance of $0.75 to $0.79 as it provides forward-looking financial targets to investors.
BVS closed at $13.15 on November 2, 2026, with the stock reaching a session high of $13.73 and a low of $13.07. These financial forecasts come as the company continues to evaluate a range of strategic options.